BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013

Dec 11, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-12-09

Reporting Person: LEWIS ALAN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-12-09	Common Stock	M	15000	$26.49	Acquired	34300	Direct
2013-12-09	Common Stock	M	7500	$38.59	Acquired	41800	Direct
2013-12-09	Common Stock	S	22500	$69.9103	Disposed	19300	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-09	Stock Option (right to buy)	$26.49	M	15000	Disposed	2021-05-11	Common Stock (15000)	Direct
2013-12-09	Stock Option (right to buy)	$38.59	M	7500	Disposed	2018-05-21	Common Stock (15000)	Direct

Footnotes

F1: The price in Column 4 is a weighted average price. The price actually received ranged from $69.7410 to $70.12. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F2: This stock option is fully vested, and therefore is currently exercisable for 100% of shares.

F3: Reflects the number of stock options outstanding after the transaction from this specific sotck option grant.